Moderna scales back forecast for 2021 Covid-19 vaccine sales, citing delivery delays

Moderna Inc. expects to deliver fewer Covid-19 vaccines than originally anticipated by the end of the fiscal year. The company says much of this is due to longer lead times for international deliveries as it shifts its priorities.